Amphastar Argues To Supreme Court: Hatch-Waxman Patent Safe Harbor Is Too Narrow

(September 1, 2016, 3:54 PM EDT) -- WASHINGTON, D.C. — An appellate court’s interpretation of the Hatch-Waxman safe harbor, 35 U.S. Code Section 271(e)(1), is “overly narrow” and puts generic manufacturers at risk of patent suits, Amphastar Pharmaceuticals...
To view the full article, register now.